This invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I); and use of a compound of Formula (I) for treating specified cancers.
This invention provides compounds of Formula (I) or a pharmaceutically acceptable salt thereof; pharmaceutical compositions comprising a compound of Formula (I); and use of a compound of Formula (I) for treating specified cancers.
POLYMORPHIC FORMS OF (S)-2-(1-(9H-PURIN-6-YLAMINO)PROPYL)-5-FLUORO-3-PHENYLQUINAZOLIN-4(3H)-ONE
申请人:Gilead Calistoga LLC
公开号:EP2834241A1
公开(公告)日:2015-02-11
US9187474B2
申请人:——
公开号:US9187474B2
公开(公告)日:2015-11-17
[EN] POLYMORPHIC FORMS OF (S)-2-(1-(9H-PURIN-6-YLAMINO)PROPYL)-5-FLUORO-3-PHENYLQUINAZOLIN-4(3H)-ONE<br/>[FR] FORMES POLYMORPHES DE L'ACIDE -2-(1-(9H-PURINE-6-YLAMINO)PROPYL)-5-FLUORO-3-PHÉNYLQUINAZOLIN-4(3H)-ONE
申请人:GILEAD CALISTOGA LLC
公开号:WO2013134288A1
公开(公告)日:2013-09-12
Polymorphs of (S)-2-(1-(9H-purin-6-ylamino)propyl)-5-fluoro-3-phenylquinazolin- 4(3H)-one, compositions thereof, methods for their preparation, and methods for their use are disclosed.